426. High Sero-Prevalence of Hepatitis B Surface Antigens among Non-Professional Health Care Workers (HCWs) at Asella Teaching Hospital, Ethiopia.
Session: Poster Abstract Session: Hepatitis B
Thursday, October 27, 2016
Room: Poster Hall
Background: Hepatitis B virus (HBV) infection is one of the major diseases and is a serious worldwide public health problem. In developing countries, HBV infection in health care workers is attributed to professional hazard because of low coverage of vaccine and infection prevention implementation. The aim of the study was to determine the prevalence of hepatitis B surface antigen (HBsAg) among Asella Teaching Hospital (ATH) staff members and compliance of vaccine.

Methods: Institutional based cross-sectional study was conducted from February, 2014 to April, 2015 in Arsi University ATH. We screened all volunteers ATH staff with HBsAg (Intec products INC (XIAMEN) China) and offered them complete dose of HBV vaccine for those HBsAg test negative individuals. Demo-graphic information of participants was documented on laboratory registration book during screening. The study was ethical cleared by Institutional review broad (IRB) of Arsi University College of Health Science. All analyses were performed by using SPSS version 20.

Results: 643 staff of ATH who volunteered were screened for HBsAg from serum. The mean age of the participant’s 32 years and 59.1% of them were females. The total prevalence of HBsAg was 6.4% (41/643) and it was 5.8% (12/207), 5.9 % (20/338), 6.7% (2/30), 7.7% (2/26), 9% (1/11), and 12.9% (4/31) among nurse and mid-wife, administration, physician, laboratory personnel, pharmacy, and non-health professional (cleaners or loader workers) respectively. The prevalence also high between the age 19-30 years old 7.5% (28/372) and >50 years old 7.4% (2/27). The compliance of the staff for HBV vaccine was 93.6%.

Conclusion: The sero-prevalence of HBV was not significantly different between HCWs and administration staff; this might be because of health professionals those know their HBV infection sero status or got vaccine not participated in the study. The prevalence was high among non-professional HCWs at the study area. The priority of infection prevention and control training, and health education should be given to them. We also highly recommend screening of all health care providers and provision of hepatitis B vaccine.

Tafese Beyene Tufa, MSc, Microbiology, Asella Teaching Hospital, College of Health Sciences and Hirsch-Institute of Tropical Medicine (HITM) Research Center, Arsi University., Asella, Ethiopia, Anteneh Girma, MD, 3Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA., Minneapolis, MN, United States Minor Outlying Islands and Desta Garoma, MD, surgeon, Surgeon, Asella Teaching Hospital, College of Health Sciences, Arsi University, Asella, Ethiopia., Asella, Ethiopia

Disclosures:

T. B. Tufa, None

A. Girma, None

D. Garoma, None

See more of: Hepatitis B
See more of: Poster Abstract Session

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.